Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 6
2020 2
2021 3
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, Morra A, Smaniotto D, Barbara R, Lozza L, Vidali C, Borghesi S, Palumbo I, Huscher A, Perrucci E, Baldissera A, Tolento G, Rovea P, Franco P, De Santis MC, Grazia AD, Marino L, Meduri B, Cucciarelli F, Aristei C, Bertoni F, Guenzi M, Leonardi MC, Livi L, Nardone L, De Felice F, Rosetto ME, Mazzuoli L, Anselmo P, Arcidiacono F, Barbarino R, Martinetti M, Pasinetti N, Desideri I, Marazzi F, Ivaldi G, Bonzano E, Cavallari M, Cerreta V, Fusco V, Sarno L, Bonanni A, Mangiacotti MG, Prisco A, Buonfrate G, Andrulli D, Fontana A, Bagnoli R, Marinelli L, Reverberi C, Scalabrino G, Corazzi F, Doino D, Di Genesio-Pagliuca M, Lazzari M, Mascioni F, Pace MP, Mazza M, Vitucci P, Spera A, Macchia G, Boccardi M, Evangelista G, Sola B, La Porta MR, Fiorentino A, Levra NG, Ippolito E, Silipigni S, Osti MF, Mignogna M, Alessandro M, Ursini LA, Nuzzo M, Meattini I, D'Ermo G. Ciabattoni A, et al. Among authors: reverberi c. Tumori. 2022 Jul;108(2_suppl):1-144. doi: 10.1177/03008916221088885. Tumori. 2022. PMID: 36112842
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes.
Valeriani M, Bonfili P, Reverberi C, Marinelli L, Ferella L, Minniti G, DE Sanctis V, Osti MF, Bonome P, Tronnolone L, Varrassi E, Gravina GL, Franzese P, Tombolini V, DI Staso M. Valeriani M, et al. Among authors: reverberi c. Anticancer Res. 2018 Mar;38(3):1671-1676. doi: 10.21873/anticanres.12400. Anticancer Res. 2018. PMID: 29491101
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques.
Tonetto F, Magli A, Moretti E, Guerini AE, Tullio A, Reverberi C, Ceschia T, Spiazzi L, Titone F, Prisco A, Signor MA, Buglione M, De Giorgi G, Trovò M, Triggiani L. Tonetto F, et al. Among authors: reverberi c. J Clin Med. 2022 Nov 23;11(23):6913. doi: 10.3390/jcm11236913. J Clin Med. 2022. PMID: 36498488 Free PMC article.
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
Trovo M, Relevant A, Polesel J, Muraro E, Barresi L, Drigo A, Baresic T, Bearz A, Fanetti G, Del Conte A, Matrone F, Reverberi C, Furlan C, Zuccon U, Fontana P, Franchin G, Minatel E. Trovo M, et al. Among authors: reverberi c. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1368-1376. doi: 10.1016/j.ijrobp.2020.11.057. Epub 2020 Nov 28. Int J Radiat Oncol Biol Phys. 2021. PMID: 33259933 Clinical Trial.
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study.
Anzellini D, DE Sanctis V, Valeriani M, Reverberi C, Marinelli L, Massaro M, Vullo G, Facondo G, Sigillo RC, Tosi E, Osti MF. Anzellini D, et al. Among authors: reverberi c. Anticancer Res. 2021 Oct;41(10):5107-5116. doi: 10.21873/anticanres.15327. Anticancer Res. 2021. PMID: 34593461 Clinical Trial.
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Reverberi C, Volpe S, Balestrini D, Buglione M, Navarria P, Scoccianti S, Panciani P, Krengli M, Pirtoli L, Bordi L, Pappagallo GL, Angelillo RMD', Magrini SM, Arcangeli S. Reverberi C, et al. J Cancer Res Clin Oncol. 2021 Mar;147(3):793-802. doi: 10.1007/s00432-021-03515-8. Epub 2021 Jan 23. J Cancer Res Clin Oncol. 2021. PMID: 33484347
17 results